NEW YORK (GenomeWeb) – In a recent filing with the US Securities and Exchange Commission, CareDx said it intends to offer for sale 3 million of its shares of common stock.

The firm has not yet priced its shares but said the proposed maximum offering price will be $2.72 per share. The proposed maximum aggregate offering price is about $9.4 million, it added.

The firm has also granted the unnamed underwriters a 30-day option to purchase up to 450,000 additional shares of common stock at the public offering price to cover any over-allotments.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.